ADTX - Aditxt, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Richmond,
United States
Type: Equity
ADTX price evolution
ADTX
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.2 | $0.22 | $0.2 | $1.96 |
| Short term investments | ||||
| Net receivables | $0.41 | $0.43 | $0.41 | $0.36 |
| Inventory | $0.57 | $0.62 | $0.75 | $0.86 |
| Total current assets | $1.51 | $1.6 | $6.91 | $3.43 |
| Long term investments | $23.28 | $22.28 | $22.28 | |
| Property, plant & equipment | $3.48 | $3.96 | $4.1 | $4.46 |
| Goodwill & intangible assets | $0.01 | $0.01 | $0.01 | $0.03 |
| Total noncurrent assets | $26.87 | $26.38 | $37.67 | $4.8 |
| Total investments | $23.28 | $22.28 | $22.28 | |
| Total assets | $28.37 | $27.98 | $44.58 | $8.23 |
| Current liabilities | ||||
| Accounts payable | $13.14 | $9.36 | $8.55 | $4.22 |
| Deferred revenue | ||||
| Short long term debt | $7.3 | $7.19 | $17.18 | $5.25 |
| Total current liabilities | $20.57 | $17.3 | $25.89 | $11.24 |
| Long term debt | $0.75 | $0.89 | $1.04 | $1.2 |
| Total noncurrent liabilities | $1.47 | $0.89 | $2.64 | $1.2 |
| Total debt | $8.04 | $8.09 | $18.22 | $6.45 |
| Total liabilities | $22.03 | $18.19 | $28.53 | $12.45 |
| Shareholders' equity | ||||
| Retained earnings | -$150.02 | -$142.47 | -$127.74 | -$116.62 |
| Other shareholder equity | ||||
| Total shareholder equity | $6.57 | $9.93 | $16.06 | -$4.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.2 | $3.12 | $8.25 | $10.57 |
| Short term investments | $0.5 | |||
| Net receivables | $0.41 | $0.53 | $0.09 | |
| Inventory | $0.75 | $0.95 | $0.49 | |
| Total current assets | $6.91 | $4.74 | $9.42 | $11.03 |
| Long term investments | $22.28 | |||
| Property, plant & equipment | $4.1 | $5.48 | $6.36 | $2.05 |
| Goodwill & intangible assets | $0.01 | $0.11 | $0.21 | $0.32 |
| Total noncurrent assets | $37.67 | $5.99 | $7.25 | $2.06 |
| Total investments | $22.28 | $0.5 | ||
| Total assets | $44.58 | $10.74 | $16.66 | $13.1 |
| Current liabilities | ||||
| Accounts payable | $8.55 | $1.96 | $1.58 | $0.24 |
| Deferred revenue | ||||
| Short long term debt | $17.18 | $1.5 | $1.85 | $0.98 |
| Total current liabilities | $25.89 | $3.64 | $3.61 | $1.23 |
| Long term debt | $1.04 | $1.89 | $2.88 | $0.86 |
| Total noncurrent liabilities | $2.64 | $1.89 | $2.88 | $0.86 |
| Total debt | $18.22 | $3.38 | $4.72 | $1.84 |
| Total liabilities | $28.53 | $5.53 | $6.48 | $2.09 |
| Shareholders' equity | ||||
| Retained earnings | -$127.74 | -$95.04 | -$67.35 | -$20.88 |
| Other shareholder equity | -$0.2 | |||
| Total shareholder equity | $16.06 | $5.21 | $10.18 | $11.01 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.04 | $0.08 | $0.08 | $0.12 |
| Cost of revenue | $0.02 | $0.07 | $0.29 | $0.11 |
| Gross Profit | $0.02 | $0.01 | -$0.2 | $0.02 |
| Operating activities | ||||
| Research & development | $1.55 | $8.15 | $4.3 | $0.9 |
| Selling, general & administrative | $4.44 | $3.4 | $3.44 | $7.21 |
| Total operating expenses | $6 | $11.55 | $7.75 | $8.11 |
| Operating income | -$5.98 | -$11.54 | -$7.95 | -$8.1 |
| Income from continuing operations | ||||
| EBIT | -$6.46 | -$12.24 | -$9.16 | -$8.84 |
| Income tax expense | ||||
| Interest expense | $1.09 | $2.49 | $1.81 | $0.91 |
| Net income | ||||
| Net income | -$7.55 | -$14.73 | -$10.97 | -$9.75 |
| Income (for common shares) | -$7.55 | -$14.73 | -$11.12 | -$9.91 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.65 | $0.93 | $0.11 | |
| Cost of revenue | $0.76 | $0.77 | $0.08 | |
| Gross Profit | -$0.11 | $0.17 | $0.03 | |
| Operating activities | ||||
| Research & development | $7.07 | $7.27 | $5.04 | $0.94 |
| Selling, general & administrative | $18.88 | $17.84 | $22.42 | $7.93 |
| Total operating expenses | $25.95 | $25.65 | $27.46 | $8.87 |
| Operating income | -$26.06 | -$25.48 | -$27.43 | -$8.87 |
| Income from continuing operations | ||||
| EBIT | -$28.19 | -$26.86 | -$46.28 | -$9.14 |
| Income tax expense | ||||
| Interest expense | $4.2 | $0.75 | $0.09 | $0.01 |
| Net income | ||||
| Net income | -$32.38 | -$27.61 | -$46.37 | -$9.15 |
| Income (for common shares) | -$32.7 | -$27.61 | -$46.37 | -$9.15 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$7.55 | -$14.73 | -$10.97 | -$9.75 |
| Operating activities | ||||
| Depreciation | $0.16 | $0.14 | $0.13 | $0.14 |
| Business acquisitions & disposals | -$1 | |||
| Stock-based compensation | $0 | $0.02 | $0.75 | $0.15 |
| Total cash flows from operations | -$2.29 | -$5.96 | -$3.31 | -$8.03 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | |||
| Investments | ||||
| Total cash flows from investing | -$1 | -$0.01 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.02 | $5.44 | $0.51 | $10.04 |
| Net borrowings | $0.87 | -$0.09 | $1.76 | $0.63 |
| Total cash flows from financing | $3.29 | $5.95 | $1.76 | $9.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0 | -$0.01 | -$1.55 | $1.56 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$32.38 | -$27.61 | -$46.37 | -$9.15 |
| Operating activities | ||||
| Depreciation | $0.54 | $0.54 | $0.48 | $0.02 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.4 | $3.13 | $4.64 | $3.19 |
| Total cash flows from operations | -$18.58 | -$22.39 | -$22.28 | -$7.22 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.37 | -$1.02 | -$0.17 |
| Investments | -$15 | |||
| Total cash flows from investing | -$0.01 | -$0.24 | -$16.31 | -$0.17 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $11.06 | $17.23 | $33.6 | $18.5 |
| Net borrowings | $4.86 | -$0.81 | $2.36 | -$0.4 |
| Total cash flows from financing | $15.92 | $17.53 | $35.95 | $17.89 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.67 | -$5.1 | -$2.63 | $10.5 |
News
Fundamentals
| Market cap | $797.48K |
|---|---|
| Enterprise value | $8.64M |
| Shares outstanding | 1.99M |
| Revenue | $329.74K |
|---|---|
| EBITDA | -$36.13M |
| EBIT | -$36.70M |
| Net Income | -$42.99M |
| Revenue Q/Q | -79.96% |
| Revenue Y/Y | -65.22% |
| P/E ratio | -0.02 |
|---|---|
| EV/Sales | 26.20 |
| EV/EBITDA | -0.24 |
| EV/EBIT | -0.24 |
| P/S ratio | 2.42 |
| P/B ratio | 0.12 |
| Book/Share | 3.29 |
| Cash/Share | 0.10 |
| EPS | -$21.56 |
|---|---|
| ROA | -157.55% |
| ROE | -607.01% |
| Debt/Equity | 1.78 |
|---|---|
| Net debt/EBITDA | -0.60 |
| Current ratio | 0.07 |
| Quick ratio | 0.05 |